The Petersen et al. group [128] studied more than 300 participants with DS at different ages, showing that plasma levels of total Tau and neurofilament light (NfL) were highly predictive of both AD pathology and clinical status in those with DS at different ages. This evidence concerns the gene NEFL and Dravet syndrome.